Lymphocyte Subsets Show Different Response Patterns to In Vivo Bound Natalizumab—A Flow Cytometric Study on Patients with Multiple Sclerosis

Natalizumab is an effective monoclonal antibody therapy for the treatment of relapsing- remitting multiple sclerosis (RRMS) and interferes with immune cell migration into the central nervous system by blocking the α(4) subunit of very-late activation antigen-4 (VLA-4). Although well tolerated and ve...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Harrer, Andrea, Pilz, Georg, Einhaeupl, Max, Oppermann, Katrin, Hitzl, Wolfgang, Wipfler, Peter, Sellner, Johann, Golaszewski, Stefan, Afazel, Shahrzad, Haschke-Becher, Elisabeth, Trinka, Eugen, Kraus, Joerg
Natura: Artigo
Lingua:Inglês
Pubblicazione: Public Library of Science 2012
Soggetti:
Research Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC3282779/
https://ncbi.nlm.nih.gov/pubmed/22363732
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0031784
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi